article thumbnail

Alternative buffer management strategies to achieve downstream process improvements

PharmaTech

Buffers are used in great quantities when producing monoclonal antibodies (mAbs), and many biopharmaceutical companies — even large ones — do not have the processing capacity or infrastructure in-house to handle these large volumes.

article thumbnail

Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials

Syner-G

Process improvements and in-person monitoring by Syner-G helped the client to get the DS with the right quality and quantity on time for Phase III clinical trials. Download The Case Study The post Process improvements and in-person monitoring help U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Strategic Guide to Reducing Procurement Costs Through Collaboration

Pharma and Life Sciences Blog

How can procurement harness synergistic processes to meet cost reduction targets? Maximizing Cost Reduction Through Collaborative Process Improvement in Procurement offers a road map for collaborative process improvement (CPI) — a structured approach to identifying cost-reduction opportunities by joining forces with suppliers.

article thumbnail

CPHI Experts Report that Small to Mid-sized US CDMOs Must Invest Now to Benefit from 2025 Contract Funding Surge

PharmaTech

Key areas to invest include manufacturing process improvements, quality management, and AI.

article thumbnail

Single-use technology propelling upstream bioprocessing market expansion

European Pharmaceutical Review

The authors also noted that growth of the upstream bioprocessing market is being pushed by the need for process improvement, and because “processing equipment consumption has expanded”.

article thumbnail

What Is Driving CPOs Today? Focus Shifts to Technology and Processes

Pharma and Life Sciences Blog

Read Now Form Title A MUST-READ FOR PROCUREMENT LEADERS Open Graph Image Show popup form Off Campaign Row 3 Addressing Top Concerns Key areas for 2024 are technology (35%), supply chain disruption (37%) and process improvement (43%) Aligning Procurement and ESG 64% say their procurement KPIs are somewhat closely linked to sustainability goals, while (..)

article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

CK Life Sciences vice-president and chief scientific officer Dr Melvin Toh said: “The cooperation with XtalPi will apply XtalPi’s AI algorithm, molecular modelling and automated experiments to speed up the R&D process, improve the success rate, and increase the efficacy of tumour vaccines.”.